|
Phenotype Analysis
|
|
Lymphocytes/mm3
|
1818
|
6000 ± 1500
|
|
CD2, %
|
70
|
73 ± 8
|
|
CD3, %
|
62
|
66 ± 13
|
|
CD4, %
|
42
|
43 ± 12
|
|
CD8, %,
|
19
|
25 ± 9
|
|
CD45RA+CD3, %
|
79
|
64 – 93
|
|
CD45RO+CD3, %
|
11
| |
|
CD25+CD4, %
|
14
|
<3
|
|
CD20, %
|
14
|
8 ± 3
|
|
smIgM, %
|
11
|
4 – 16
|
|
smIgM, %
|
10
|
3 – 15
|
|
CD56, %
|
10
|
13 ± 7
|
|
Lymphoproliferative Responses
|
|
PHA, cpm
|
164,082
|
100,530 – 657,376
|
|
%NR
|
65
|
>50
|
|
Con A, cpm
|
10
|
53,173 – 502,758
|
|
%NR
|
0
|
>50
|
|
PWM, cpm
|
121,168
|
40,305 – 337,597
|
|
%NR
|
96
|
>50
|
|
MLC, cpm
|
118,219
|
43,801 – 328,175
|
|
SI
|
23.2
|
>3.0
|
|
Immunoglobulins
|
|
IgG, mg/dl
|
113
|
399–1068
|
|
IgA, mg/dl
|
11
|
15–95
|
|
IgM, mg/dl
|
97
|
49–202
|
|
IgE, IU/ml
|
<2
|
3–29
|
|
anti-HiB, μg/ml
|
<0.5
|
>1.0
|
|
anti-Diphtheria toxoid, IU/ml
|
1.61
|
>0.05
|
|
anti-Tetanus toxoid, IU/ml
|
0.2
|
>0.5
|
|
anti-Streptococcus, μg/ml
|
|
Serotype 4
|
4.6
|
>2.0
|
|
Serotype 6
|
2.2
|
>2.0
|
|
Serotype 9
|
0.3
|
>2.0
|
|
Serotype 14
|
1.0
|
>2.0
|
|
Serotype 18
|
12.2
|
>2.0
|
|
Serotype 19
|
0.9
|
>2.0
|
|
Serotype 23
|
0.3
|
>2.0
|
|
CH50, U/ml
|
64
|
31 – 64
|
